AUTHOR: Jennie

Patent protects the precision of MRS data capture within the target disc — a critical step in the Nociscan workflow Designed to reduce scan time, support faster technologist onboarding and deliver more reproducible results across imaging centers Extends Aclarion’s IP protection to over 65 issued and pending patents worldwide, complementing its broader portfolio covering spectroscopy […]

Partnership brings Nociscan for chronic low back pain to one of the nation’s leading neurosurgery and spine care networks Goodman Campbell Brain & Spine is recognized nationally for its role in neurosurgery training and clinical research Availability of Nociscan in Indiana reflects Company’s focus on expansion and adding to its growing base of provider sites […]

Dear Fellow Shareholders, The first half of 2026 marked an important period of execution and momentum for Aclarion. We entered the year focused on three priorities: accelerating clinical adoption of Nociscan®, advancing reimbursement and evidence generation milestones, and maintaining the financial discipline required to deliver on our value creating catalysts. At midyear, we continue to […]

141% year-over-year scan volume growth in first half of 2026 Reimbursement momentum in the U.K. translating into consistent scan volume growth Launched Market Access Program in partnership with PRIA Healthcare to secure insurance coverage for Nociscan in the U.S. Continued progress toward the CLARITY trial readout with the addition of multiple new trial sites Strengthened […]

Abstracts presented at American Society of Pain & Neuroscience (ASPN) annual meeting across surgical decision support and basivertebral nerve ablation Early findings from real-world evidence study demonstrate immense utility and ability of Nociscan to be incorporated into clinical practice Case study represents first reported use of Nociscan to guide basivertebral nerve ablation in a patient […]

Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient’s pain before recommending treatment CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan® aims to become the gold standard in identifying sources […]

Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion’s AI-driven platform for chronic low back pain. Program aims to follow successful reimbursement wins in the UK that are translating into sustained scan volume growth in step with reduced market access barriers BROOMFIELD, Colo. — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare […]

Expands availability of Nociscan in the greater Los Angeles area with leading neuroscience group Adds to growing body of real-world evidence with study comparing chemical biomarker data from Nociscan with bone metabolic information from SPECT-CT  Supports scalable growth strategy while building data assets critical to payer and provider adoption BROOMFIELD, Colo. — Aclarion, Inc., (“Aclarion” or […]

  Award-winning, NIH funded study indicates that immune-associated biological signatures may play a role in some cases of back pain Nociscan’s underlying MRS technology enabled measurement of intradiscal propionic acid to uncover immune-linked patient subtypes Latest findings point to potential clinical applications of Nociscan beyond surgical decision support, expanding the future scope of precision spine […]

“Matching the right procedure to the right patient is what moves the field forward” Lanman Spinal Neurosurgery is a leading spine-focused private practice recognized for its expertise in complex spinal procedures, early adoption of innovative technologies and high surgical volume The CLARITY randomized clinical trial is designed to demonstrate Nociscan’s ability to improve surgical outcomes […]